XML 60 R45.htm IDEA: XBRL DOCUMENT v3.25.2

Redeemable Convertible Preferred Stock and Stockholders' Deficit (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

Summary of Reserved for Issuance Upon the Potential Conversion or Exercise

The number of shares of Common Stock that have been reserved for issuance upon the potential conversion or exercise, as applicable, of the Company's securities as of December 31, 2024, is as follows:

Outstanding options to purchase Common Stock			265,772
Restricted Stock Units			104,500
Warrants to purchase Common Stock			767,697
Shares of Common Stock issued upon the exercise of Public Warrants			750,383
Earn-Out shares			360,000
Convertible Notes			2,532,336
Total			4,780,688

Summary of Warrants to Purchase the Classes of Preferred Stock and Common Stock Outstanding

As of December 31, 2024, there were 14,589 Rollover Warrants outstanding to purchase Common Stock. Upon the closing of the Business Combination, certain Legacy Allurion preferred stock and Legacy Allurion common stock warrants that were converted into Rollover Warrants were determined to be equity classified.

In connection with the Public Offering and Private Placement, we issued the Public Offering Warrants and Private Placement Warrants. As of December 31, 2024, there were 662,701 Public Offering Warrants and 90,407 Private Placement Warrants outstanding to purchase Common Stock.

December 31, 2024
Issuance Date		Remaining Contractual Term (in years)				Underlying Equity Instrument		Balance Sheet Classification		Shares Issuable Upon Exercise of Warrant				Weighted Average Exercise Price
12/1/2014			-0.1			Common stock		Equity			209			$	61.00
3/30/2021			6.2			Common stock		Liability			5,203				168.25
9/15/2022			7.7			Common stock		Liability			1,810				303.50
6/4/2022			7.4			Common stock		Liability			1,810				303.50
1/17/2017			2.0			Common stock		Equity			2,934				0.50
8/3/2017			2.6			Common stock		Equity			392				28.25
9/8/2017			2.7			Common stock		Liability			1,151				26.25
6/19/2018			3.5			Common stock		Liability			720				26.25
6/25/2019			4.5			Common stock		Liability			360				26.25
7/1/2024			4.5			Common stock		Liability			753,108				30.00
											767,697

December 31, 2023
Issuance Date		Remaining Contractual Term (in years)				Underlying Equity Instrument		Balance Sheet Classification		Shares Issuable Upon Exercise of Warrant				Weighted Average Exercise Price
12/1/2014			0.9			Common stock		Equity			1,771			$	61.00
3/30/2021			7.2			Common stock		Liability			5,203				168.25
9/15/2022			8.7			Common stock		Liability			1,810				303.50
6/4/2022			8.4			Common stock		Liability			1,810				303.50
1/17/2017			3.0			Common stock		Equity			2,934				0.50
8/3/2017			3.6			Common stock		Equity			392				28.25
9/8/2017			3.7			Common stock		Liability			1,151				26.25
6/19/2018			4.5			Common stock		Liability			720				26.25
6/25/2019			5.5			Common stock		Liability			360				26.25
											16,151

X

- Definition

Schedule of common stock reserved for future issuance.

+ References

No definition available.

+ Details

Name:	alur_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
Namespace Prefix:	alur_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration